[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Outcomes of Autism Treatment Using Naltrexone

What is the purpose of the study?

The purpose of this study is to collect information from the patients we treat for autism spectrum disorders in order to evaluate our treatment methods and report the outcomes of our treatment approaches in medical journals.

Upstate Institutional Review Board (IRB) Number:

721816

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Brian Johnson

Who can I contact for more information?

Name: Jacqueline M Hattersley
Phone: 315-464-3130
Email: hattersj@upstate.edu

Return to Previous Page || Search Again

Top